UF Health Researchers Join National Study of COVID-19 Impacts on Health Workers, Potential Remedies
A new research program to understand the effect of COVID-19 on health care workers is soon to be underway at University of Florida Health and other sites across the country. A clinical trial to evaluate whether hydroxychloroquine can prevent COVID-19 infections is also being planned.
The Healthcare Worker Exposure and Outcomes, or HERO, initiative has two parts — a registry and a clinical trial. The registry, which comes out of Duke University, will enroll up to 100,000 health care workers nationally who are at risk of developing the COVID-19 infection. Registry members will then be eligible for a clinical trial of hydroxychloroquine’s effectiveness in preventing COVID-19 infection in health care workers, called the HERO-HCQ trial.